Preventative Maintenance and Service Support for Thermo Fisher Scientific HERA VIOS 160i CO2 and VIOS 250i CO2 Incubators

The National Institutes of Health (NIH), Clinical Center (CC), Department of Transfusion Medicine (DTM), Center for Cellular Engineering (CCE), intends to procure preventative maintenance and service support for thirty-six (36) Thermo Fisher Scientific incubators, consisting of thirty-two (32) HERA VIOS 160i CO2 incubators and four (4) VIOS 250i CO2 incubators, for the period of performance January 16, 2027, through March 15, 2028. CCE manufactures patient-specific cellular therapies under Food and Drug Administration (FDA)-regulated Current Good Manufacturing Practice (cGMP) conditions in support of clinical trials conducted at the NIH Clinical Center. These incubators are critical to validated cell-manufacturing processes and require .... Read More